Education in Pharmacogenomics


The European Pharmacogenomics Clinical Implementation Project (U-PGx) performed a survey about pharmacogenomic knowledge among 70 healthcare professionals in 2017. Of participants, 84,3% found pharmacogenomics relevant to their current practice, but experience was still rare. Two-thirds (65,7%) did not order nor recommend a pharmacogenomic test during the past year. This was mainly attributed to lack of sufficient knowledge about pharmacogenomics (40%).

Needs were identified in application of pharmacogenomics: Identifying drugs (41.4%) and interpreting test results (37.2%) as well as underlying mechanisms as better knowledge on drug metabolism (67.1%), better knowledge of basic principles of pharmacogenomics (60.0%). The study analysed the specific attitudes, experience and education regarding pharmacogenomics of future users. There was a generally positive attitude towards pharmacogenomic testing. However, the level of personal experience, and lack of knowledge about application and interpretation of pharmacogenomics caused uncertainty. Thus, education and training programmes may be helpful for implementation of pharmacogenomics at a homogenous level within Europe.

On-line version of the U-PGx study by Susanne Just et al.: doi:10.1007/s00228-017-2292-5


A Danish survey investigating the public opinion about genetic tests demonstrated that 90% of the Danes find gene tests more exciting than disquieting. Among participants, 83% would take a gene test if it could help them to a better and more targeted treatment for their disease ( (Danish public healthcare website).

Hence, citizens are pro gene testing and healthcare professionals have a generally positive attitude towards pharmacogenomics. All users express interest in further education in the technology. Genetelligence have developed a seven module webinar education, which can be accessed day and night as webinars in English and German. The content is based on contributions from distinguished experts in the field. The education progamme is not promoting Personal Medicine Profile and is not influenced by the pharmaceutical industry.

Learn more about pharmacogenomics at

 Module 1: Introduction to pharmacogenomics  Module 2. Legal affairs in EU Module 3. Regulatory guidelines on pharmacogenomics Module 4. Pharmacokinetics and -dynamics, Module 5. Genotyping in the laboratory, Module 6. Clinical utility of pharmacogenomics Module 7. Clinical cases on pharmacogenomics.

Find the education at

Trusted Partners

Genetelligence focus on services, research and development in the field of personalized medicine. Therefore, we work with a wide range of private and public institutions. Please, feel free to contact us for possible cooperation.